Anti-CEBPA Polyclonal Antibody from ProteoGenix; catalogue ARO-A22052; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-CEBPA Polyclonal Antibody
The Anti-CEBPA Polyclonal Antibody is a highly specific and sensitive tool for the detection of CEBPA protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the CEBPA protein sequence. It has been extensively validated for use in various experimental techniques, making it a reliable choice for your research needs.
CEBPA, or CCAAT/enhancer binding protein alpha, is a transcription factor that plays a crucial role in the regulation of gene expression. It is involved in a wide range of cellular processes, including differentiation, proliferation, and apoptosis. CEBPA is also known to be a key regulator of hematopoiesis, making it an important target for studies in the field of biotechnology and medicine.
The Anti-CEBPA Polyclonal Antibody is specifically designed for use in immunohistochemistry (IHC), western blotting (WB), and immunofluorescence (IF) techniques. It has been optimized to provide high sensitivity and specificity, making it suitable for a variety of applications in both basic and clinical research.
This antibody has been successfully used in a variety of experimental settings, including the detection of CEBPA in cancer cell lines, tissues, and patient samples. It has also been used to study the role of CEBPA in various diseases, such as acute myeloid leukemia and liver cancer. Additionally, it has been used to investigate the effects of different treatments and interventions on CEBPA expression and function.
In summary, the Anti-CEBPA Polyclonal Antibody is a reliable and versatile tool for the detection and study of CEBPA protein. Its high specificity and sensitivity, along with its proven success in various experimental techniques, make it an ideal choice for researchers interested in understanding the role of CEBPA in different biological processes and diseases. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A22052. For research use only.
Target: CCAAT/enhancer-binding protein alpha; C/EBP alpha; CEBPA; CEBP; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| CCAAT/enhancer-binding protein alpha; C/EBP alpha; CEBPA; CEBP |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
